-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RxO9qWh764Gkjwsxqcb+FKlRrZgNXGSjP2NObBpa9SWfkP1zevs9XsgeV3L2rJc4 6+mdU5TftK0cLnZiKM9RtA== 0001254316-05-000040.txt : 20050426 0001254316-05-000040.hdr.sgml : 20050426 20050426171935 ACCESSION NUMBER: 0001254316-05-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050422 FILED AS OF DATE: 20050426 DATE AS OF CHANGE: 20050426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOYER HERBERT W PH D CENTRAL INDEX KEY: 0001016351 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09813 FILM NUMBER: 05773950 BUSINESS ADDRESS: BUSINESS PHONE: 7147524500 MAIL ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92715 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2005-04-22 0 0000318771 GENENTECH INC DNA 0001016351 BOYER HERBERT W PH D 1 DNA WAY SO SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2005-04-22 4 M 0 8000 32.84 A 35500 D Common Stock 2005-04-22 4 S 0 8000 70 D 27500 D Common Stock 2005-04-22 4 M 0 20000 18.6 A 47500 D Common Stock 2005-04-22 4 S 0 20000 70 D 27500 D Non-Qualified Stock Option (right to buy) 18.6 2005-04-22 4 M 0 20000 0 D 2003-04-23 2013-04-23 Common Stock 20000 0 D Non-Qualified Stock Option (right to buy) 32.84 2005-04-22 4 M 0 8000 0 D 2000-05-15 2010-05-15 Common Stock 8000 0 D This stock option vests over one year in equal monthly increments beginning one month from grant date. This option may be immediately exercisable with the consent of Genentech. This stock option vests over four years, with the first 25% of the shares vesting one year from the grant date and 75% of the shares vesting in equal monthly increments over the following three years. This option may be immediately exercisable with the consent of Genentech. By: Karen L. Strand, Attorney-in-Fact For: Herbert W. Boyer 2005-04-26 -----END PRIVACY-ENHANCED MESSAGE-----